Weighing in on fistula failure

Kidney International

Volumn 71, Issue 1, 2007, Pages 12-14

  Dixon, B S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HEMODIALYSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; OBESITY; OXIDATIVE STRESS; PENETRATING TRAUMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SURGICAL INJURY; SURGICAL RISK; VASCULAR ACCESS; VEIN DIAMETER; VENOUS STASIS;

EID: 33845716192     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002021     Document Type: Note

References (10)

1. Kats M, Hawxby AM, Barker J, Allon M. Impact of obesity on arteriovenous fistula outcomes in dialysis patients. Kidney Int 2007; 71: 39-43.
2. Dixon BS. Why don't fistulas mature? Kidney Int 2006; 70: 1413-1422.
3. Stracke S, Konner K, Kostlin I et al. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 2002; 61: 1011-1019.
4. Yao Q, Pecoits-Filho R, Lindholm B et al. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol 2004; 38: 405-416.
5. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006; 38: 64-80.
6. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800.
7. Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16(Suppl 1): S83-S88.
8. Labarrere CA, Zaloga GP. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 2004; 117: 499-507.
9. Alessi MC, Lijnen HR, Bastelica D et al. Adipose tissue and atherothrombosis. Pathophysiol Haemost Thromb 2003; 33: 290-297.
10. Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 2006; 12: 163-168.